Abstract:Background/Objectives: Homocysteine (Hcy) and iron are factors co-related with the progression of cardiovascular diseases. The vascular endothelium is an important barrier for physiological homeostasis, and its impairment initiates cardiovascular injury. However, the mechanism underlying Hcy-caused vascular endothelial cell injury and the participation of iron are not fully elucidated. This study aims to investigate the Hcy-induced vascular endothelial injury and iron metabolism dysfunction as well as the underlying molecular mechanism. Methods: Human umbilical vein endothelial cells (HUVECs) were employed as the experimental model to examine the Hcy-induced endothelial injury and its underlying mechanism via various biochemical assays. Results: Hcy suppressed the cell viability and proliferation and caused cell death in a concentration-dependent manner. Hcy induced cell cycle arrest, apoptosis, and autophagy as well as impairment of intracellular energy metabolism. Hcy disrupted the intracellular antioxidant system and mitochondrial function by increasing intracellular ROS, MDA and mitochondrial content, and decreasing the SOD activity and mitochondrial membrane potential. Hcy significantly reduced the GSH-Px activity along with the accumulation of intracellular GSH in a concentration-dependent manner. Ferroptosis inhibitors, Ferrostatin-1 (Fer-1), and Deferoxamine (DFO) significantly decreased the Hcy-caused cytotoxicity accompanied by a reduction in dysregulated mitochondria content, but only DFO ameliorated the elevation of intracellular ROS, and neither Fer-1 nor DFO affected the Hcy-caused reduction in intracellular ATP. In addition, Hcy decreased the intracellular concentration of iron, and supplementing Hcy with various concentrations of Fe3+ increased the cell viability and decreased the LDH release in a concentration-dependent manner. Hcy dramatically decreased the mRNA expression level of transferrin receptor while increasing the mRNA expression levels of transferrin, ferritin light chain, ferritin heavy chain, ferroportin, and SLC7A11. Moreover, Hcy suppressed the protein expression of phosphor-Akt, phosphor-mTOR, Beclin-1, LC3A/LC3B, Nrf2, HO-1, phosphor-MEK1/2, phosphor-ERK1/2, and Caspase-3 in concentration- and time-dependent manners. Conclusions: Hcy-induced vascular endothelial injury is likely to be associated with apoptosis and autophagy, but not ferroptosis. The key underlying mechanisms are involved in the disruption of the intracellular antioxidant system and iron metabolism via regulation of PI3K/Akt/mTOR, MAPKs, Nrf2/HO-1, and iron metabolism.

Downregulation of Folate Receptor Α Contributes to Homocysteine‑induced Human Umbilical Vein Endothelial Cell Injury Via Activation of Endoplasmic Reticulum Stress.

Homocysteine Induces Apoptosis of Human Umbilical Vein Endothelial Cells via Mitochondrial Dysfunction and Endoplasmic Reticulum Stress

Interference in mevalonate pathway ameliorates homocysteine-induced endothelium-dysfunction.

Effect of homocysteine on expression of interleukin-6 and NF-kappa B activity in cultured rat vascular smooth muscle cells

Effect of Homocysteine on Expression of Intercellular Adhesion Molecule-2 and Adhesion of Dendritic Cells to Cultured Human Umbilical Vein Endothelial Cells

Homocysteine Causes Vascular Endothelial Dysfunction by Disrupting Endoplasmic Reticulum Redox Homeostasis.

Folic acid inhibits homocysteine-induced cell apoptosis in human umbilical vein endothelial cells

Possible Involvement of NADPH Oxidase and JNK in Homocysteine-Induced Oxidative Stress and Apoptosis in Human Umbilical Vein Endothelial Cells.

Folate Protects Hepatocytes of Hyperhomocysteinemia Mice from Apoptosis Via Cystic Fibrosis Transmembrane Conductance Regulator (Cftr)-Activated Endoplasmic Reticulum Stress

Homocysteine Induces 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase in Vascular Endothelial Cells

Inhibitive Effects of Atorvastatin on Homocysteine-Induced Endoplasmicreticulum Stress in Human Umbilical Vein Endothelial Cells

Homocysteine facilitates endoplasmic reticulum stress and apoptosis of hepatocytes by suppressing ERO1α expression via cooperation between DNMT1 and G9a

Homocysteine Impaired Endothelial Function Through Compromised Vascular Endothelial Growth Factor/Akt/Endothelial Nitric Oxide Synthase Signalling

Effect of n-3 polyunsaturated fatty acid on gene expression of the critical enzymes involved in homocysteine metabolism

Intracellular Iron Deficiency and Abnormal Metabolism, Not Ferroptosis, Contributes to Homocysteine-Induced Vascular Endothelial Cell Death

Disturbance of Copper Homeostasis Is a Mechanism for Homocysteine-Induced Vascular Endothelial Cell Injury

Valsartan Attenuated Homocysteine-Induced Impaired Autophagy and ER Stress in Human Umbilical Vein Endothelial Cells

Homocysteine impaired endothelial function via compromised VEGF/Akt/eNOS signaling (Revised 1)

Moderate Elevation of Homocysteine Induces Endothelial Dysfunction through Adaptive UPR Activation and Metabolic Rewiring

Homocysteine Inhibits Human Umbilical Vein Endothelial Cells Proliferation Through Cell Cycle G1 / S Arrest

THE PATHOGENIC MECHANISM OF HOMOCYSTEINE -INDUCED ENDOTHELIAL NITRIC OXIDE SYNTHASE DYSFUNCTION AND THE ANTAGONISTIC EFFECTS BY FOLIC ACID